3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Completed
70
Unknown
38
Recruiting
38
Terminated
16
Not yet recruiting
8
Active not recruiting
7
Withdrawn
5
Suspended
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Neoplasms
35
Breast Neoplasms
30
Prostatic Neoplasms
22
Leukemia, Myeloid, Acute
20
Colorectal Neoplasms
20
Melanoma
17
Pancreatic Neoplasms
16
Glioblastoma
16
Carcinoma, Non-Small-Cell Lung
16
Neoplasm Metastasis
15
Lung Neoplasms
13
Brain Neoplasms
13
Glioma
12
Stomach Neoplasms
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Myelodysplastic Syndromes
11
Carcinoma, Hepatocellular
11
Ovarian Neoplasms
10
Multiple Myeloma
9
Head and Neck Neoplasms
9
Triple Negative Breast Neoplasms
8
Lymphoma
8
Carcinoma, Renal Cell
8
Leukemia
7
Sarcoma
6
Rectal Neoplasms
6
Hematologic Neoplasms
6
Esophageal Neoplasms
6
Uterine Cervical Neoplasms
5
Recurrence
5
Interventions
Radiotherapy
1
Oxaliplatin
1
Menogaril
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Suspended
×
Interventional
×
Radiation Injuries
×
Clear all
NCT05820633
2025-09-12
PCS-XI
CHU de Quebec-Universite Laval
Phase NA
Suspended
500 enrolled
NCT02121405
2022-05-11
PSSR
Zhejiang University
Phase 3
Suspended
350 enrolled